Stocks and Investing Stocks and Investing
Wed, January 3, 2024

Jayson Bedford Maintained (ABT) at Buy with Increased Target to $124 on, Jan 3rd, 2024


Published on 2024-10-28 08:10:07 - WOPRAI, Jayson Bedford
  Print publication without navigation


Jayson Bedford of Raymond James, Maintained "Abbott Laboratories" (ABT) at Buy with Increased Target from $110 to $124 on, Jan 3rd, 2024.

Jayson has made no other calls on ABT in the last 4 months.



There are 4 other peers that have a rating on ABT. Out of the 4 peers that are also analyzing ABT, 1 agrees with Jayson's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • David Lewis of "Morgan Stanley" Maintained at Hold with Decreased Target to $107 on, Thursday, October 19th, 2023


These are the ratings of the 3 analyists that currently disagree with Jayson


  • Lawrence Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $121 on, Wednesday, December 13th, 2023
  • Joanne Wuensch of "Citigroup" Maintained at Strong Buy with Increased Target to $123 on, Monday, December 11th, 2023
  • Matt Miksic of "Barclays" Maintained at Buy with Increased Target to $133 on, Thursday, October 19th, 2023

Contributing Sources